NCT03229486View on ClinicalTrials.gov

Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 30, 2019

Study Completion Date

December 30, 2019

Conditions
Emergence Delirium
Interventions
DRUG

Sugammadex Injection [Bridion]

Return to T2 point (two contractions) on TOF device is replied by iv 2 mg/kg sugammadex administration, contained in a blinded syringe.

DRUG

Neostigmine+Glycopyrronium

Return to T2 point (two contractions) on TOF device is replied by iv 0.06 mg/kg neostigmine and 0.005 mg/kg glycopyrrolate administration, contained in a blinded syringe.

Trial Locations (1)

50612

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER

NCT03229486 - Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia | Biotech Hunter | Biotech Hunter